MICONAZOLE NITRATE

Search structure
Trade Names:
Synonyms:
Status: Approved (1974)
Entry Type: Small molecule
Molecule Category: Salt
UNII: VW4H1CYW1K
Parent Compound: MICONAZOLE

Structure
InChI Key MCCACAIVAXEFAL-UHFFFAOYSA-N
Smile Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O
InChI
InChI=1S/C18H14Cl4N2O.HNO3/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22;2-1(3)4/h1-8,11,18H,9-10H2;(H,2,3,4)

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H15Cl4N3O4
Molecular Weight 479.15
AlogP 6.45
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 6.0
Polar Surface Area 27.05
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 25.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Cytochrome P450 51 inhibitor PubMed PubMed PubMed PubMed Wikipedia
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Transporter Electrochemical transporter SLC superfamily of solute carriers SLC21/SLCO family of organic anion transporting polypeptides
- - - - 120

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Tinea Pedis 2 D014008 ClinicalTrials
Candidiasis, Vulvovaginal 2 D002181 ClinicalTrials

Related Entries

Scaffolds

Parent
Mixture

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Reproductive system and breast disorders
35.47
General disorders and administration site conditions
22.89
Skin and subcutaneous tissue disorders
10.07
Injury, poisoning and procedural complications
8.03
Vascular disorders
5.15
Gastrointestinal disorders
3.38
Nervous system disorders
2.36
Immune system disorders
2.02

Cross References

Resources Reference
ChEBI 6923
ChEMBL CHEMBL1559
FDA SRS VW4H1CYW1K
Guide to Pharmacology 2449
KEGG C08070
PubChem 68553
SureChEMBL SCHEMBL15799
ZINC ZINC00896740
CONTENTS